AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06052111 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Group D (dexmedetomidine group)
Description: The patients received loading dose of dexmedetomidine (1 μg/kg) (Precedex, Abbot Laboratories Inc., Abbot Park, IL, USA) intravenously over 15 minutes before induction of anesthesia followed by continuous infusion at a rate of (0.6 μg/ kg/ hr) after intubation and was stopped 10 minutes before the end of surgery.
Study NCT06060158 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: 6 sessions
Study NCT06161233 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CAPABLE cohort
Description: The CAPABLE cohort receives the mobileapplication and a multi-sensorial smartwatch (ASUS VivoWatch 5 HC-B05). Patients will be asked to use the system for at least 6 months. The CAPABLE app serves three main functionalities for the patient: symptom monitoring, information needs fulfilment and interventions to improve mental- and physical wellbeing
Study NCT05467033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desmopressin
Description: desmopressin 0,3ug/kg in 100ml 0,9% NaCl managed as intravenous infusion;
Study NCT05467033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous infusion NaCl
Description: 0,9% NaCl managed as intravenous infusion
Study NCT05467033 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: intravenous infusion NaCl
Description: 0,9% NaCl managed as intravenous infusion
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: 24-hour dietary recall
Description: Dietary intake assessment conducted by a Registered Dietitian Nutritionist. This assessment will occur prior to starting R-CHOP chemotherapy, during the clinic visits for each round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: Hand grip strength
Description: Measurement of grip strength using a hand dynamometer. This will test occur prior to starting R-CHOP chemotherapy, during the clinic visits for each round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: International Physical Activity Questionnaire
Description: Survey about physical activity over the previous 7 days. This survey will be administered prior to starting R-CHOP chemotherapy, during the clinic visits for each round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: Patient-reported outcomes survey
Description: Survey about symptoms and side effects experienced during cancer treatment. This will be administered prior to starting R-CHOP chemotherapy, during the clinic visits for each round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: Pittsburgh Sleep Quality Index
Description: Survey about sleep habits and quality over the past month. This will be administered prior to starting R-CHOP chemotherapy, during the clinic visits for each round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: Functional Assessment of Cancer Treatment - Lymphoma
Description: Survey about quality of life for people with a diagnosis of lymphoma. This will be administered prior to starting R-CHOP chemotherapy, during the clinic visits for each round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: urine sample (optional)
Description: Collect three urine samples either in the clinic or at home. This specimen collection will occur prior to starting R-CHOP chemotherapy, after the third round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT04293900 — intervention group
Intervention type: OTHER
Intervention: fecal sample (optional)
Description: Collect a fecal sample either in the clinic or at home. This sample collection will occur prior to starting R-CHOP chemotherapy, after the third round of R-CHOP chemotherapy, and again at the end of the scheduled course of R-CHOP chemotherapy.
Study NCT06093438 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Patients enrolled in this arm would receive three cycles of induction treatment before receiving definitive chemoradiotherapy. The specific regimen is: Paclitaxel(135mg/m2,ivd, d1)+cisplatin(75mg/m2,ivd,d1-3)+Toripalimab (240mg,ivd,d1)±bevacizumab(ivd, d1)/q21d. Patients would receive pelvic MRI to evaluate the regression status of tumor after three cycles of induction treatment. Patients with satisfying tumor regression would receive definitive chemoradiotherapy afterwards. During chemoradiotherapy, patients would receive weekly cisplatin (40mg/m2) and 240mg toripalimab every three weeks. After chemoradiotherapy, patients would receive another three cycles of consolidated treatment (regimen identical to induction treatment).
Study NCT06208891 — intervention group
Intervention type: PROCEDURE
Intervention: Robotic myomectomy
Description: Robotic assisted laparoscopic myomectomy
Study NCT05701059 — intervention group
Intervention type: DEVICE
Intervention: Unconstrained Biomet Zimmer Mobi-C
Description: This unconstrained, three-piece implant will be administered by cervical arthroplasty into the specified single-level cervical region.
Study NCT05114993 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: wearing a disposable surgical mask
Description: Physiologic vital signs will be monitored every minute for 5 minutes without a mask, followed by every minute for 15 minutes with a surgical mask.
Study NCT05563571 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolon, Lidocaine
Description: Intra-articular cortisone injection
Study NCT05563571 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed radiofrequency, Lidocaine
Description: pulsed radiofrequency of shoulder joint and suprascapular nerve
Study NCT06193733 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Dendritic Cell
Description: Biological: Immunotherapy with dendritic cells
Study NCT05119699 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MagPro X100/R30 stimulator equipped with the B70 fluid-cooled coil
Description: Subjects will receive 5 consecutive days (always Monday to Friday) of TBS rTMS, administered 8 times daily at 1 hour intervals. Patients will undergo cTBS of the R DLPFC at 110-120% RMT using bursts of 3 pulses at 50 Hz, bursts repeated at 5 Hz for a total of 600 pulses over 40 seconds, followed by iTBS of the L DLPFC at 110-120% resting motor threshold (RMT) using bursts of 3 pulses at 50 Hz, bursts repeated at 5 Hz with a duty cycle of 2 s on, 8 s off for a total of 600 pulses over 3 min 9 s. Participants will be titrated to 110-120% RMT within the first four treatments to aid with tolerability. If patients tolerate the stimulation well, the target will be 120%. Assessments focused on depressive symptoms will be administered at baseline, after final treatment and four weeks post final treatment.
Study NCT05201599 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flexible ureteroscope with intelligent control of renal pelvic pressure
Description: After adjusting the UAS in suitable position, the pressure sensory and suctioning channels are connected to the irrigation and suctioning platform. After being injected with water, a zero calibration is performed for the pressure sensory system. A fully automatic mode is selected on the platform. The perfusion flow is set between 50 to 150 mL/min. The RPP control value is set between -15 to -5 mmHg. The renal pelvic pressure alarm value is set between 20 to 30mmHg. During the operation, a holmium laser is used to break stones into powder (fiber diameter 200 µm), and the flexible ureteroscopy is moved back and forward slightly to suck out the stone particles inside the sheath gap. Particles larger than the sheath gap but smaller than the UAS is sucked out by intermittently withdrawing the flexible ureteroscope without basket.
Study NCT05648188 — intervention group
Intervention type: BIOLOGICAL
Intervention: Sample
Description: Sample of whole blood and tissue for ex vivo expression of A2R, CD39, CD73 and P2RX7
Study NCT05511545 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Education Booklet
Description: Excretory system organs, signs and symptoms to be seen in kidney and ureteral stones, treatment methods, ureteroscopy procedure, what to do before and on the morning of surgery, and surgery, using the training booklet prepared by the researchers in line with the recommendations of the European Association of Urology and the relevant literature. An average of 25-30 minutes of training was given in the patient's room in an encouraging language, allowing the patient to ask questions about the situations he would encounter in the clinic after the surgery. She started asking questions she didn't understand. Afterwards, the questions of the patients were answered and the patient was given a training booklet.
Study NCT00706888 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamins B6, B9 and B12 and polyphenols
Study NCT00706888 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT06226844 — intervention group
Intervention type: DEVICE
Intervention: Music therapy walking program
Description: In the experimental group (PEMA BeatMove), patients will benefit from an outpatient walking training program with app-based performance monitoring, combined with music therapy (BeatMove device). The program comprises 36 walking training sessions, with 30
Study NCT06041711 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia with propofol induction and sevoflurane maintenance
Description: Surgical procedure is performed under general anesthesia with propofol induction and mainteined with sevoflurane inhalation.
Study NCT06041711 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Regional anesthesia with neuroaxial blockage
Description: Surgical procedure is performed under regional anesthesia. Patients are sedated with 2 mg intravenous midazolam. Combined spinal epidural anesthesia or spinal anesthesia with PENG block is used for anesthesia and analgesia.
Study NCT05497050 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family education
Description: By calling the families in the experimental group by phone; Nursing interventions for family empowerment will last for 10 weeks, they will be invited to the Family Health Center (FHC) or child metabolism polyclinic twice in this process, they will be called once a week (with 2 phone calls) for two weeks after the face-to-face training initiative in the first stage, In the second stage, at the end of the face-to-face training, they will be informed that they will be called once a week for two weeks (4 phone calls in total). The families in the experimental group will be informed that 4 weeks after the completion of the training and phone calls (at the 10th week), they will call the FHC or the pediatric metabolism polyclinic again for the application of the post-tests and that the nursing training for family empowerment will be completed.
Study NCT04906967 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: flaps
Description: coverage of soft tissue defect around ankle
Study NCT05838131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Experimental: CAR-T cells Infusion
Description: Biological:~chimeric antigen receptor T cells
Study NCT05665673 — intervention group
Intervention type: OTHER
Intervention: Physical functions test
Description: Participants; sociodemographic and descriptive data will be recorded. The Standardized Mini-Mental Test will be used for the global cognitive assessment of participants, the Brunnstrom staging to assess lower extremity motor recovery and indicate at what motor level, and the Functional Ambulation Classification to classify them according to the basic motor skills required for functional ambulation. Gait and balance assessment will be evaluated with Tinetti Balance and Gait Assessment (POMA), functional exercise capacity will be evaluated with 6 Minute Walking Test (6MWT), and peripheral muscle strength will be evaluated with knee extension strength.
Study NCT05416476 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anisodine Hydrobromide
Description: Anisodine Hydrobromide 1 mg oral tablet, twice times a day
Study NCT05416476 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Anisodine Hydrobromide placebo
Description: Anisodine Hydrobromide Placebo 1 mg oral tablet, twice times a day
Study NCT06509685 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ladder Training
Description: 9 participants will perform only Ladder training exercise protocol. The training schedule included exercises such as Two foot run, Ladder traps, Lateral angle leg hops, Single leg forward hop, two-foot lateral run, Fight shuffle, Skiers, Carioca, Lateral in out, two in two out, Intermediate high knee run, Straddle squat hops, two foot laterals hop in \& out, Two-foot lateral hop, Ali shuffle, 180 Degree rotation, jumping jacks' variation, Advanced in in out, Quick hops cotch, Icky shuffle etc. For each session, ten stations were used and participants change the partner after every end of steps jumping exercise and continued each exercise at least 3 set, depending on the class design(22).
Study NCT06509685 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: balance training
Description: 9 participants will perform balance training protocol. The balance training program includes exercises based around balance development in unilateral dynamic balancing positions. The program included balance and landing activities incorporating wobble boards and change of direction activities.
Study NCT05142774 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tapinarof cream, 1%
Description: Tapinarof cream, 1%, applied daily to affected areas by subjects or their caregivers based on vIGA-AD. Subjects are advised to choose the application time they prefer and apply the study drug at that approximate time each day of study participation.
Study NCT04274790 — intervention group
Intervention type: PROCEDURE
Intervention: Scheduled and planned surgery
Description: Collection of tumour samples from samples collected as part of standard patient management. Diagnostic pathological analysis will be a priority. These samples will be taken by experienced staff during the hospital visit scheduled as part of standard care.
Study NCT05491291 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patients with chronic wound of the lower limbs
Description: The rating scale will be passed at three different times, day 1, day 15 and day 75.
Study NCT05059106 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Half dose of ChAdOx1 nCoV-19 (AZD1222)
Description: Vaccination with reduced dose (half dose) of ChAdOx1 nCoV-19 (AZD1222), in a 2-dose schedule with an interval of 8 weeks, including all adults aged 18 to 49 years, from non-priority groups, from Viana city - Espírito Santo (ES)/Brazil.
Study NCT05059106 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard dose of ChAdOx1 nCoV-19 (AZD1222)
Description: Vaccination with standad dose of ChAdOx1 nCoV-19 (AZD1222), in a 2-dose schedule with an interval of 8 weeks, in external cohort of health workers aged 18 to 49 years.
Study NCT05486000 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atrial shunt implant system
Description: Patients with chronic left heart failure who meet the conditions of the clinical trial undergo interventional surgery with the Atrial Shunt Implant System
Study NCT05516030 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: HIFT for people with MRD
Description: 12-wk, 3x/week HIFT participation for individuals with MRD
Study NCT04727411 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: XEN45 Gel stent
Description: XEN Gel stent implantation either combined or as a stand-alone procedure
Study NCT04727411 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Trabeculectomy
Description: XEN Gel stent implantation either combined or as a stand-alone procedure
Study NCT05801185 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unilateral lower limb suspension
Description: Participants will perform a 5-day unloading intervention using the ULLS model. Short-length crutches, aided by handgrip and forearm support distal to the elbow will be used to assist in any upright or ambulatory activity. One foot (randomized in a counterbalance manner) will be equipped with a shoe having a 10-cm thick sole, which permits the unloaded limb to move passively about the hip joint while adopting a near straight position.
Study NCT05956860 — intervention group
Intervention type: PROCEDURE
Intervention: abdominopelvic vascular intervention through the radial artery access
Description: According to the pathological changes and needs of the subjects (any abdominal and pelvic arterial intervention that can be performed through the radial artery access, including but not limited to:~1. hepatic intervention, such as transarterial chemoembolization (TACE), hepatic arterial infusion chemotherapy (HAIC), etc.;~2. Other visceral intervention, such as spleen, kidney, mesentery, etc.;~3. Pelvic intervention, such as uterine artery embolism, prostatic artery embolism, etc.;~4. Others, such as preoperative embolization of bone tumors (lumbar, sacral vertebra), etc.
Study NCT06488742 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: 3% kanuka oil
Description: To assess the efficacy in patients with mild atopic dermatitis, 3% kanuka oil will be applied twice a day for 28 days. 3% kanuka oil is a naturally occurring extract from the kanuka tree and is considered an over-the-counter agent.
Study NCT06488742 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3% kanuka oil
Description: To assess the efficacy in patients with mild atopic dermatitis, 3% kanuka oil will be applied twice a day for 28 days. 3% kanuka oil is a naturally occurring extract from the kanuka tree and is considered an over-the-counter agent.
Study NCT04778813 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine
Description: In each study site, children fulfilling the inclusion criteria will be assigned randomly to one of three treatment groups: AL, DHA-PPQ or As-Pyr group. Sealed envelopes each containing no more than 10 other small envelopes with randomization numbers and treatment will also be provided. These will be used over time, respecting the ascending order of the numbers to randomly distribute the eligible children after selection in each of the three treatment groups. The treatment to be administered will not be known until after the randomization process. The drugs will be administered based on weight according to the instructions from the drug manufacturer. AL will be administered with fatty food or milk according to the manufacturer's recommendations. All doses of the drug will be administered under the direct supervision of a qualified team member designated by the principal investigator.
Study NCT05469165 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyproheptadine 4 Mg Oral Tablet
Description: Cyproheptadine treatment for 3 months
Study NCT05469165 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administration for 3months
Study NCT05949866 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movement and Cognition Intervention Group
Description: Preschool centers assigned to the Movement and Cognition (MAC) group will receive the 6-month intervention, which will be implemented 4 days per week. To ensure consistency of intervention delivery, centers will be provided with the MAC modules on a bi-weekly basis. The MAC intervention will be implemented using a train-the-trainer (gradual release) model. This will be a gradual release model, in which interventionist will first serve as a co-provider and will eventually serve in a support role, as providers become primary implementers.~The MAC intervention will consist of gross motor skill curriculum consists of 30 individual lesson plans. The number of days needed to instruct each lesson plan activities ranges between 3 to 5 days. In each lesson, specific instruction and activities are designed to teach fundamental movements (e.g., running, leaping, kicking, jumping, throwing, catching).
Study NCT05949866 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health Tracker Group (Control Group)
Description: Preschool centers assigned to the health tracker g group will be asked to maintain their usual daily schedule and to not participate in other physical activity programs during the 6-month intervention.
Study NCT06363968 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RETeval
Description: as previous
Study NCT05752227 — intervention group
Intervention type: PROCEDURE
Intervention: Transthoracic biopsy
Description: Us guided transthoracic biopsy
Study NCT05752227 — intervention group
Intervention type: RADIATION
Intervention: CT chest
Description: Computed tomography
Study NCT05109598 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant new coronavirus vaccine (CHO cell)
Description: Intramuscular injection of deltoid muscle of upper arm of 25μg/0.5ml/person /dose Recombinant new coronavirus vaccine (CHO cells).